December 3, 2024
The PSA (Prostate-Specific Antigen) test measures a protein produced by the prostate gland. It's used to screen for prostate cancer, monitor treatment, and detect recurrence. While useful, PSA testing should involve informed decision-making with healthcare providers.
PSA is a protein specific to the prostate gland. Elevated levels can indicate prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis. However, many factors affect PSA levels, making interpretation complex.
PSA levels increase with age, urinary tract infection, recent ejaculation, and vigorous cycling. A single elevated PSA should be rechecked. PSA velocity (rate of change) is more meaningful than absolute values for cancer detection.
Medical organizations vary on screening recommendations. Generally, informed decision-making is recommended for men 40-69 years old. Men at higher risk (African American men, those with family history) should discuss screening at age 40. Risk-benefit discussions should precede testing.
Elevated PSA is often rechecked to confirm elevation, as levels can fluctuate.
Distinguishes benign from malignant elevations. Low free PSA percentage increases cancer risk.
Physical examination assessing prostate size and abnormalities.
Performed if cancer is suspected to obtain tissue diagnosis.
No special preparation is required. Avoid recent ejaculation (48 hours before test if possible), intense exercise, and urinary tract procedures. A simple blood draw provides the sample.
Divine Healthcare provides PSA testing with expert counseling. Make informed decisions about your prostate health screening.
Book Test